Allergan PLC on Friday lost a last-minute bid to delay an upcoming trial in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.
U.S. District Judge Denise Casper in Boston denied Allerganâ€™s request to stay the case pending its appeal of her November 2017 decision to certify a class of health plans and other indirect purchasers of the drugs.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2DPH3to
 